Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | SYR |
nurse accidentally administered a Priorix vaccine intravenously instead of intramuscularly; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 36-year-old female patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix (intravenous). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: nurse accidentally administered a Priorix vaccine intravenously instead of intramuscularly). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-APR-2025 Pharmacist called to report that a nurse accidentally administered a Priorix vaccine intravenously instead of intramuscularly, which led to subcutaneous injection formulation administered by other route. The reporter wanted to know was there any advice or safety concern on this situation No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.